Free Trial

HLS Therapeutics (TSE:HLS) Trading Down 1.8% - Here's Why

HLS Therapeutics logo with Medical background

HLS Therapeutics Inc. (TSE:HLS - Get Free Report) fell 1.8% during trading on Monday . The stock traded as low as C$3.89 and last traded at C$3.89. 32,710 shares were traded during trading, an increase of 20% from the average session volume of 27,313 shares. The stock had previously closed at C$3.96.

Analyst Ratings Changes

Separately, Raymond James increased their price objective on shares of HLS Therapeutics from C$4.00 to C$5.00 in a research note on Friday, November 22nd.

View Our Latest Stock Analysis on HLS

HLS Therapeutics Stock Performance

The company has a debt-to-equity ratio of 100.44, a quick ratio of 1.01 and a current ratio of 2.02. The stock has a market cap of C$119.85 million, a P/E ratio of -3.73 and a beta of 1.07. The business's 50-day moving average price is C$3.56 and its 200-day moving average price is C$3.47.

About HLS Therapeutics

(Get Free Report)

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.

Read More

Should You Invest $1,000 in HLS Therapeutics Right Now?

Before you consider HLS Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HLS Therapeutics wasn't on the list.

While HLS Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains

2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains

The natural gas and LNG sector is heating up again! 🔥 MarketBeat analyst Thomas Hughes discusses why 2025 could be a comeback year for natural gas.

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines